Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Autoimmune enteropathy"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Conditions: Diarrhea;   Gastrointestinal Complications;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Biological: filgrastim;   Drug: cyclophosphamide

Indicates status has not been verified in more than two years